PhD Grzegorz Kreiner



Assistant professor at Institute of Pharmacology PAS, Dept. Brain Biochemistry. Principal Investigator on two research grants funded by National Science Center (NCN):

Opus2 2011/03/B/NZ7/05949: Pharmacological evaluation of possible neuroprotective strategies in novel gentic mouse models of progressive neurodegeneration (2012-2015)

Opus7 2014/13/B/NZ7/02293: Evaluation of the role of transcription factor CREB in the mechanism of antidepressant treatment: study on the novel genetic models based on the Cre/loxP system (2015-2018)

more_publications
  • Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genetic models based on the Cre/loxP system - 2015-01-27 - 2018-02-26
    Grant NCN OPUS 7 (2015-2018)nr 2014/03/B/NZ7/02293Kierownik projektu: dr Grzegorz Kreiner


  • Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodegeneration, based on tissue specific inducible Cre/loxP system - 2012-08-22 - 2016-04-21
    Grant NCN OPUS 2 (2012-2016)nr 2011/03/B/NZ7/05949Kierownik projektu dr Grzegorz Kreiner
  • Investigation of noradrenergic and glucocorticoid system interactions in GRDBHCre mice and their evaluation as a potential model of depression - research task 1.2 - 2010-01-01 - 2014-12-31
    Grant POIG (NCBiR) DeMeTer "Depression – Mechanisms – Therapy"POIG.01.01.02-12-004/09 (2010-2014)Main Goal (1): Modeling of depression - etiology learning strategy"
    Research Task (1.2) coordinator: dr Grzegorz Kreiner

national

international

  • Dr Andrii Domanskyi, Institute of Biotechnology, University of Helsinki, Finland
  • Dr Rosanna Parlato, Institute of Applied Physiology, University of Ulm, Germany
Copyright © 2017